BUZZ - Becton Dickinson stock rises as 2026 earnings forecast raised and Q3 results exceed expectations

October 29 - ** Medical device manufacturer Baxter International (BAX.N) saw its shares rise 4.3% in premarket trading to $26.55

** The company has raised (link) its annual adjusted earnings per share forecast from the previous range of $1.95 to $2.15 to a range of $2.05 to $2.15

** According to data compiled by London Stock Exchange Group (LSEG), BAX reported third quarter adjusted earnings per share of 58 cents, exceeding analysts’ expectations of 52 cents

** Third quarter revenue reached $2.98 billion, above the expected $2.91 billion

** Full-year revenue is now expected to grow by 4% to 5%, up from the previously forecast 3% to 4%

** As of the previous trading day’s close, BAX shares have gained 33.2% year-to-date

(To facilitate non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text. Automated translations are provided for reader convenience only. Reuters assumes no responsibility for any harm or loss caused by the use of automated translation functions.)